These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6379512)

  • 1. [Radioimmunological evaluation of the technical loss of insulin added to infusion solutions].
    Scherini A; Maestrone E; Della Torre P; Osti G; Pradella G
    Minerva Anestesiol; 1984 Mar; 50(3):63-5. PubMed ID: 6379512
    [No Abstract]   [Full Text] [Related]  

  • 2. Availability of insulin from parenteral nutrient solutions.
    Weber SS; Wood WA; Jackson EA
    Am J Hosp Pharm; 1977 Apr; 34(4):353-7. PubMed ID: 404875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin kinetics in hyperalimentation solution and routine intravenous therapy.
    Tate JT; Cowan GS
    Am Surg; 1977 Dec; 43(12):811-6. PubMed ID: 413462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential life-threatening variations of drug concentrations in intravenous infusion systems: potassium chloride, insulin, and heparin.
    Bergman N; Vellar ID
    Med J Aust; 1982 Sep; 2(6):270-2. PubMed ID: 6755202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of whole blood on insulin adsorption onto intravenous infusion systems.
    Kerchner J; Colaluca DM; Juhl RP
    Am J Hosp Pharm; 1980 Oct; 37(10):1323-5. PubMed ID: 6999896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical signigicance of insulin adsorption by polyvinyl chloride infusion systems.
    Hirsch JI; Fratkin MJ; Wood JH; Thomas RB
    Am J Hosp Pharm; 1977 Jun; 34(6):583-8. PubMed ID: 406784
    [No Abstract]   [Full Text] [Related]  

  • 7. Availability of insulin from continuous low-dose insulin infusions.
    Whalen FJ; LeCain WK; Latiolais CJ
    Am J Hosp Pharm; 1979 Mar; 36(3):330-7. PubMed ID: 420226
    [No Abstract]   [Full Text] [Related]  

  • 8. [Synthetic material used for infusion containers and equipment].
    Herner M
    Klin Anasthesiol Intensivther; 1977; (14):21-33. PubMed ID: 556572
    [No Abstract]   [Full Text] [Related]  

  • 9. Review of glass types available for packaging parenteral solutions.
    Sanga SV
    J Parenter Drug Assoc; 1979; 33(2):61-7. PubMed ID: 255148
    [No Abstract]   [Full Text] [Related]  

  • 10. [Efficacy of continuous administration of insulin by subcutaneous route in the treatment of insulin-dependent diabetes mellitus].
    Dupré J
    Journ Annu Diabetol Hotel Dieu; 1982; ():221-35. PubMed ID: 7047839
    [No Abstract]   [Full Text] [Related]  

  • 11. [Letter: Filter for blood and infusions].
    Valseth A; Heisto H
    Tidsskr Nor Laegeforen; 1973 Sep; 93(27):2065-6. PubMed ID: 4766391
    [No Abstract]   [Full Text] [Related]  

  • 12. Interactions between drugs and intravenous delivery systems.
    Kowaluk EA; Roberts MS; Polack AE
    Am J Hosp Pharm; 1982 Mar; 39(3):460-7. PubMed ID: 7072732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Continuous predetermined insulin infusion in insulin-dependent diabetes, mellitus (author's transl)].
    Jean R; Rolin B
    Ann Pediatr (Paris); 1981 Sep; 28(7):481-3. PubMed ID: 7025728
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial: Contamination of intravenous fluids.
    N Z Med J; 1975 Mar; 81(535):259. PubMed ID: 1055324
    [No Abstract]   [Full Text] [Related]  

  • 15. Compatibility of diazepam with intravenous fluid containers and administration sets.
    Parker WA; MacCara ME
    Am J Hosp Pharm; 1980 Apr; 37(4):496-500. PubMed ID: 7377212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Continuous predetermined infusion in insulin dependent diabetes in children and adolescents. A comparative study in relation to insulin infusion and duration of diabetes (author's transl)].
    Jean R; Rolin B; Viguier JL; Morel G; Branchet A
    Ann Pediatr (Paris); 1981 Sep; 28(7):485-92. PubMed ID: 7025729
    [No Abstract]   [Full Text] [Related]  

  • 17. Surface properties of glass containers for parenteral solutions.
    Adams PB
    Bull Parenter Drug Assoc; 1977; 31(5):213-26. PubMed ID: 922239
    [No Abstract]   [Full Text] [Related]  

  • 18. Thiamine destruction by sodium bisulfite in infusion solutions.
    Scheiner JM; Araujo MM; DeRitter E
    Am J Hosp Pharm; 1981 Dec; 38(12):1911-3. PubMed ID: 7325171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [ADSORPTION OF INSULIN TO INFUSION EQUIPMENT].
    BRUNFELDT K; HORSDAL P; JORGENSEN KR; POULSEN JE
    Nord Med; 1964 Aug; 74():843-4. PubMed ID: 14335199
    [No Abstract]   [Full Text] [Related]  

  • 20. [The influence of multiple sterilization on the quality of polypropylene containers for parenteral solutions (author's transl)].
    Eustachiewicz E
    Ann Univ Mariae Curie Sklodowska Med; 1978; 33():249-53. PubMed ID: 757935
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.